Medicare to cover CAR-T. Italians use payment at results. The Navy introduces value-based care. Democrats’ plans to limit drug prices. Using contingent valuation to weight quality measures. Public health spending increases GDP.


How accurate are RVUs? Capturing the patient voice. Tools for physicians to find patient copays for drugs. New generic EpiPen hits the market. An honest man. Is Mechanical Turk trustworthy for surveys?

Experts debate Trump drug pricing policies

What will Trump’s “favored nation” policy do to drug prices and innovation? How will 340B reforms affect the price hospitals charge for drugs? Myself and my colleague Jim Baumgardner weigh in with our thoughts in an article in FormularyWatch. “US drug prices will certainly fall. However, prices outside the US will rise,” Jason Shafrin, PhD,…

Mid-week links

Netflix model pricing for HCV drugs in Louisiana. Does “genetic nurture” cause obesity among siblings? New head of the CEA. Will health departments allow kids who don’t get a chickenpox vaccine to go to private school? “…many preferred to avoid viewing comparative clinical outcomes, particularly survival” I’m generally in favor of increased use of NPs,…

Trump Executive Order to Mandate Price Transparency for Providers

As the N.Y. Times reports, more transparency is coming to provider prices. The White House released an executive order Monday afternoon intended to require insurance companies, doctors and hospitals to give patients more information about precisely what their care will cost before they get it. More transparency is generally good and surprise billing for out-of-network costs has been a major…